ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,436.44
-0.50%
US Tech 100
18,346.40
-1.13%
Dow Jones
40,743.33
0.50%
Brent Oil
78.565
-0.73%
Bitcoin
66,245.01
-0.87%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Hydrogenone Capital Growth Plc (HGEN) Quote

Hydrogenone Capital Growth Plc

Hydrogenone Capital Growth Plc (HGEN)

Global X Management AUS Ltd
Humanigen Inc
Humanigen Inc (CE)
50.40
0.30
(0.60%)
Closed July 30 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
50.40
Bid
50.00
Ask
50.80
Volume
97,246
50.00 Day's Range 50.60
40.70 52 Week Range 63.00
Market Cap
64.925M
Previous Close
50.10
Open
50.60
Last Trade
101
@
50.472
(O)
Last Trade Time
Financial Volume
49,186p
VWAP
50.5792
Average Volume (3m)
168,572
Shares Outstanding
128,819,999
Dividend Yield
-
PE Ratio
41.32
Earnings Per Share (EPS)
0.01
Revenue
3.28M
Net Profit
1.55M

About Hydrogenone Capital Growth Plc

Sector
Trust,ex Ed,religious,charty
Industry
Trust,ex Ed,religious,charty
Website
www.hydrogenonecapitalgrowthplc.com
Headquarters
London, Gbr
Founded
1970
Hydrogenone Capital Growth Plc is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker HGEN. The last closing price for Hydrogenone Capital Growth was 50.10p. Over the last year, Hydrogenone Capital Growth shares have traded in a share price range of 40.70p to 63.00p.

Hydrogenone Capital Growth currently has 128,819,999 shares outstanding. The market capitalization of Hydrogenone Capital Growth is £64.54 million. Hydrogenone Capital Growth has a price to earnings ratio (PE ratio) of 41.32.

HGEN Latest News

More News

Form 8-K - Current report

July 25 2024
Edgar (US Regulatory)

COLUMBIA BANKING SYSTEM, INC. REPORTS SECOND QUARTER 2024 RESULTS

COLUMBIA BANKING SYSTEM, INC. REPORTS SECOND QUARTER 2024 RESULTS PR Newswire TACOMA, Wash., July 25, 2024 TACOMA, Wash., July 25, 2024 /PRNewswire/ --  $120 million $140...

July 25 2024
PR Newswire (US)

Columbia Banking System Announces Date of Second Quarter 2024 Earnings Release and Conference Call

Columbia Banking System Announces Date of Second Quarter 2024 Earnings Release and Conference Call PR Newswire TACOMA, Wash., June 28, 2024 TACOMA, Wash., June 28, 2024 /PRNewswire/ -- Columbia...

June 28 2024
PR Newswire (US)

Umpqua Bank 2024 Business Barometer: U.S. Middle Market Optimism Surges, While Small Businesses Proceed Cautiously

Umpqua Bank 2024 Business Barometer: U.S. Middle Market Optimism Surges, While Small Businesses Proceed Cautiously PR Newswire LAKE OSWEGO, Ore., June 13, 2024 Middle Market: Optimism soars to...

June 13 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

May 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.91.8181818181849.553.249.522142251.18092833DE
4-2.3-4.3643263757152.75449.511665951.69945326DE
121.83.703703703748.658.648.116857253.9864267DE
26-1.4-2.702702702751.858.640.719461349.24105084DE
520.71.4084507042349.76340.716677350.62131039DE
156-51.6-50.588235294110212738.5523174381.88603251DE
260-51.6-50.588235294110212738.5523174381.88603251DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ARGOArgo Group Limited
6.00p
(50.00%)
259.88k
KZGKazera Global Plc
0.50p
(33.33%)
7.94M
CRTXCrism Therapeutics Corporation
17.50p
(29.63%)
386.75k
STJSt. James's Place Plc
698.00p
(24.98%)
5.24M
VALValirx Plc
2.85p
(18.75%)
1.93M
GEXMining Minerals & Metals Plc
13.875p
(-68.75%)
10.6M
JOGJersey Oil And Gas Plc
69.50p
(-20.11%)
613.19k
UKOGUk Oil & Gas Plc
0.071p
(-19.13%)
5.55B
PIPPipehawk Plc
1.45p
(-17.14%)
67.25k
PREMPremier African Minerals Limited
0.0585p
(-15.22%)
494.1M
UKOGUk Oil & Gas Plc
0.071p
(-19.13%)
5.55B
VASTVast Resources Plc
0.115p
(17.95%)
964.26M
MSMNMosman Oil And Gas Limited
0.056p
(-11.81%)
767.49M
TRPTower Resources Plc
0.0115p
(9.52%)
513.18M
INSPInspirit Energy Holdings Plc
0.0095p
(-5.00%)
507.46M

Discussion

View Full Feed
wrinklesobw wrinklesobw 59 seconds ago
Hi sc8 junior. I like how you twist everything to your benefit. If it was denied they would have to start all essentially.

What don’t you understand that the FDA did not have enough time to go through everything. They essentially have gone through 90-95 percent of the data given.
RDGL
PennyPusher786 PennyPusher786 59 seconds ago
This management has to force a short squeeze somehow to keep the vultures away.
BNED
leverage102 leverage102 1 minute ago
NSAV $$$$. PREDICTIONS FOR TOMORROW ?? $$$$ A DOUBLE $$$$$$$$. MAYBE IMHO $$$$$$$$$. Bid Changed from .0042 to .008 ? IDK LET JUST %$UCKING GO $$$$$$$$$$$$$$$$$$$$$
NSAV UCKING
BDEZ BDEZ 1 minute ago
Since Jan. 2020 the debt has ballooned by 50% from $23 trillion to $35 trillion.

https://x.com/WallStreetSilv/status/1817978215606206838
KILLAZILLA KILLAZILLA 1 minute ago
TYPICAL NONSENSE FROM KNOWN SHILL...

XERI
Nemesis18 Nemesis18 1 minute ago
Lol DStock, you're getting more desperate by the day, as you attempt to join these imaginary dots that only exist in your head.

But I suspect that you will only get worse, as you see your invested money further disappear over the coming week or so.

There's nothing like
NWBO
Viewmont Viewmont 2 minutes ago
Hey janetcanada! Good to see you!
ABQQ looks good huh! 40% up today! This can move up fast with some good news!
Good Luck!
ABQQ
1vman 1vman 2 minutes ago
***** Just a matter of time ERBB gets sent to the Expert Market for good !

OUCH JUST OUCH

ENOUGH SAID
ERBB
Bubae Bubae 2 minutes ago
Shawn Leon has juiced this about all he can since the beginning of June and retail isn't getting excited. It might have something to do with the Leons taking a majority stake and saying that they not only intend to split this into the multi dollar level but come with the dilutive offering afterwards
GRST
learningcurve2020 learningcurve2020 2 minutes ago
So he didn't say it you all just said he did. I see.
NWBO
PennyPusher786 PennyPusher786 3 minutes ago
I would consider a provEN OTC ticker at this point such that has room to grow like $CEOS

These nasdaq bioplays suck... pure reverse Splits and share offerings and barely ever a buyout or product that comes to fruition. Just CEOs and management using retail money to keep their income r
CEOS
JoJr JoJr 3 minutes ago
Do you know of this guy?
Charles Nenner
He offers a 30 day free trial, no credit card needed...
Pretty straightforward and informative on all markets with charts and graphs.
Daily reports three times a day monitoring trends.
Here's his web site.
https://w
BDEZ BDEZ 3 minutes ago
So ch, looks like Maduro & that lady are both no good?
Filterthenoise Filterthenoise 3 minutes ago
Had to be done IGPK Now LFG!
IGPK
WorstLuck WorstLuck 4 minutes ago
Descriptive.

They do have P1 ADC trials ongoing:
https://clinicaltrials.gov/study/NCT03575819?cond=PROSTATE%20CANCER&term=for46&rank=1
https://clinicaltrials.gov/study/NCT05011188?cond=PROSTATE%20CANCER&term=for46&rank=2

Doesn't make them look like more th
trademax42 trademax42 4 minutes ago
Love the transparency in this company. Keeping shareholders informed, can't say the same for many OTC companies. Thanks Viewmont for doing the good work. Member marked # 80

From MMG! 7/30/2024
$HIRU DRAFT 8K DONE!!
Sent for approval & legal review. 3:30pm Est here 1030p
HIRU
jglider jglider 4 minutes ago
How do you walk 3,000? miles thru Mexico with no support or so it seems. Arrive at the border many grossly overweight, cell phones, new back packs etc and again no support?
Viewmont Viewmont 5 minutes ago
https://x.com/PikachOTC/status/1818372433659019739
HIRU
Capt_Smith77 Capt_Smith77 5 minutes ago
Speaking of capitulating shorts, it looks like NVDA is moving much higher after hours today, as both Microsoft and AMD (shocking, I know) have reported strong results related to AI spending and paint a picture of where NVIDIA investors likely stand come earnings.

I would post some of
AMD NVDA
delerious1 delerious1 5 minutes ago
"So why are posters upset at zero share bashers?"
There is more to that description but it was left out in respect to the thread here....but it is a phrase used to describe self proclaimed "stock reviewers" and "truth tellers" on the site here that decide if stocks are suitable for others, u
tat4tat tat4tat 6 minutes ago
Big upcoming conference should give it a boost. Aug 4 - 7 th.
SYTA
rogers711 rogers711 6 minutes ago
Definitely not a gloom scenario, this wasn’t approved because there was issues with the submittal, period. Take from that what you wish but if their info submitted was adequate it would have been approved… it wasn’t and they are now amending the submittal. This is very clear and easy to understand,n
RDGL

Your Recent History

LSE
HGEN
Hydrogenone Capital Growth
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved